Search Results

Addressing Barriers in Advancing Equitable Biomarker Testing in Community Oncology

Biomarker or molecular testing to help oncologists match patients with the best cancer treatment can be challenging in the community oncology setting and for patients in underserved communities. At present,...

CMV Prophylaxis in Kidney Transplant: Examining New Solutions to an Old Problem

Post-transplant cytomegalovirus (CMV) infection afflicts as high as 80% of kidney organ transplant recipients, resulting in life-threatening direct complications, long-term negative outcomes, and significant morbidity and mortality. Current first-line antivirals...

Take Action: Optimizing Equity in Cardiology Care

...such as lower rates of hypertension control, increased cardiovascular mortality, and limited access to necessary care. For example, non-Hispanic Black patients experience a 50% higher risk of cardiovascular mortality compared...

Who, What, and Why of Biomarker Testing in Ovarian Cancer

...biomarkers, current and emerging therapies, and how the latest clinical trial data translates to real-world practice. Biomarker testing, particularly for ovarian cancer (OC), can be especially promising, helping to identify...

Tailoring Care: Crafting Individualized and Patient-Centered Narcolepsy Treatment Plans

...team established treatment goals and measured treatment response over time. Additional patient case examples that require application of learned topics will also be discussed to better translate knowledge into practice....

Anticoagulation Considerations in Renally-Impaired Patients with NVAF or VTE: Case Simulations and Commentary

...and candid commentary punctuated by clinical tips and pearls you can use in your own practice.      Among the topics covered: Should stroke and VTE prophylaxis take precedent over...

Take Action: Optimizing Equity in Mental Health Care

Disparities in mental health diagnosis, treatment, and outcomes significantly affect racial, ethnic, and LGBTQIA+ groups. These populations face barriers such as lower diagnosis rates, inadequate treatment, and poorer outcomes compared...